Kodiak Sciences Inc (KOD)
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Precigen Inc (PGEN)
Precigen Reports Third Quarter 2025 Financial Results and Business Updates
ImmuCell Corporation (ICCC)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
Sera Prognostics Inc (SERA)
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Evofem Biosciences, Inc. (EVFM)
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update
Equillium Inc. (EQ)
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
Hyperfine Inc (HYPR)
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
Trevi Therapeutics Inc. (TRVI)
Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Vaxart Inc (VXRT)
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M